PMIS2
Transmembrane protein PMIS2
Also known as: IFITMD9, PMIS2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A1W2PS18
- Gene
- PMIS2
- Ensembl
- ENSG00000283758
- Chromosome
- 19
- Canonical length
- 150 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to act upstream of or within binding activity of sperm to zona pellucida. Predicted to be active in intracellular membrane-bounded organelle and membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
150 residues, UniProt reviewed canonical sequence.
>A0A1W2PS18|PMIS2
1 MALKPPSATQ PAPNAPATPD APPTTGDPGA SAAPGSPTTT GGPGAPAEVP QEPQEPTQTP
61 EELAFYAPNY LCLTIFAILL FPPFGLAALY FSYEGSWTQK PTSMLPPLQT MKANQNSEWE
121 EAYINSGRTG WFGAFVVMIG LGIIYGLVLYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PMIS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 0.7 nTPM
Expression across tissuesHPA
Tissue
- testis: 0.7 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
Single-cell type
- late spermatids: 34 nCPM
- early spermatids: 15 nCPM
- late primary spermatocytes: 12 nCPM
- early primary spermatocytes: 0.3 nCPM
- cdc: 0.1 nCPM
- gonadotrophs: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 3.6 nTPM
- cerebral cortex: 0.2 nTPM
- pons: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PMIS2 as an antibody target. Whether an autoantibody or antibody against PMIS2 could matter depends on whether native PMIS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PMIS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PMIS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...